Scientific Programme
The 30th Annual Meeting Scientific Committee established an inspiring programme* on the topic "Progressive MS from pathology to treatment".
* Changes to the programme may apply.
| Hour Location |
Title | Location |
|---|---|---|
|
10:00 - 11:00 |
Satellite Symposium - Merck Global Medical Affairs - MS has one course |
|
|
11:15 - 12:15 |
Satellite Symposium - Sanofi - If You Think MS is Silent, You’re Not Listening: Turning Up the Volume on Smouldering Disease and Progressive MS |
|
|
12:15 - 13:30 |
Light Lunch & Poster Viewing Session I (Basic Studies Part 1) |
|
|
13:30 - 13:45 |
Opening & Introduction Giancarlo Comi |
|
|
13:45 - 14:15 |
XXX ECF Lecture Giancarlo Comi |
|
|
14:15 - 15:45 |
Session I - Pathology Tanja Kuhlmann |
|
| 14:15 - 14:35 |
What defines progression in pathology Hans Lassmann |
|
| 14:35 - 14:55 |
Role of cortical lesions Roberta Magliozzi |
|
| 14:55 - 15:15 |
Axonal and synaptic pathology and failure of repair Christine Stadelmann |
|
| 15:15 - 15:35 |
Slowly expanding lesions Stephan Bramow |
|
| 15:35 - 15:45 |
Q&A |
|
|
15:45 - 17:45 |
Session II - Mechanistic aspects Ariel Miller |
|
| 15:45 - 16:05 |
Energy failure Don J. Mahad |
|
| 16:05 - 16:25 |
Role of acquired and innate immunity Wee Yong |
|
| 16:25 - 16:45 |
Immunosenescence Heinz Wiendl |
|
| 16:45 - 17:05 |
What determines the efficiency of remyelination? Robin Franklin |
|
| 17:05 - 17:15 |
Q&A |
|
|
17:15 - 18:15 |
Coffee Break & Poster Viewing Session II (Clinical + Treatment) |
|
|
18:15 - 19:15 |
Satellite Symposium - Bristol Meyers Squibb (BMS) - Brain Preservation and Cognition in MS: MRI Biomarkers, Early Awareness and the Role of S1P-R Modulators |
|
|
19:15 - 20:00 |
Scientific Networking Cocktail |
| Hour Location |
Title | Location |
|---|---|---|
|
07:30 - 08:30 |
Satellite Symposium - Merck MS in the 21st Century - How can we better support PwMS at diagnosis and beyond? An MS in the 21st Century (MS21) discussion |
|
|
08:30 - 10:00 |
Session III - Contribution of epidemiology to understanding progression Maria Trojano |
|
| 08:30 - 08:50 |
Risk factors for secondary progressive MS Jan Hillert |
|
| 08:50 - 09:10 |
Prognostic factors in progressive MS (including aging and comorbidities) Mar Tintoré |
|
| 09:10 - 09:30 |
PIRA and silent progression Ludwig Kappos |
|
| 09:30 - 09:50 |
Do we need a revision of the classification of MS courses Fred Lublin |
|
| 09:50 - 10:00 |
Q&A |
|
|
10:00 - 10:30 |
Coffee Break & Poster Viewing Session III (Epidemiology + Investigations) |
|
|
10:30 - 12:00 |
Session IV - Biomarkers Hans-Peter Hartung |
|
| 10:30 - 10:50 |
Slowly Expanding Lesions (SELs) on MRI Douglas L. Arnold |
|
| 10:50 - 11:10 |
PET Bruno Stankoff |
|
| 11:10 - 11:30 |
Body fluid biomarkers in progressive MS: NfL and beyond Jens Kuhle |
|
| 11:30 - 11:50 |
Functional biomarkers (including wearable devices) Letizia Leocani |
|
| 11:50 - 12:00 |
Q&A |
|
|
12:00 - 13:00 |
Satellite Symposium (GME) - Central inflammation in MS: Suspects and future solutions |
|
|
13:00 - 14:00 |
Light Lunch +Poster Viewing Session IV (Basic Studies Part. 2) |
|
|
14:00 - 15:30 |
Session V - Clinical trials designs and outcomes Bernard M.J. Uitdehaag |
|
| 14:00 - 14:20 |
Early phase trials: exploring efficacy and disease biology Marco Salvetti |
|
| 14:20 - 14:40 |
Phase III RCTs Robert Fox |
|
| 14:40 - 15:00 |
Phase II and III RCTs for remyelination Catherine Lubetzki |
|
| 15:00 - 15:20 |
Large studies interventions Jeremy Chataway |
|
| 15:20 - 15:30 |
Q&A |
|
|
15:30 - 17:00 |
Session VI - Treatment of PMS today Gilles Edan |
|
| 15:30 - 15:50 |
Approved MS DMTs Xavier Montalban |
|
| 15:50 - 16:10 |
Physical rehabilitation Peter Feys |
|
| 16:10 - 16:30 |
Cognitive rehabilitation Dawn Langdon |
|
| 16:30 - 16:50 |
Future perspectives in symptomatic treatments Oscar Fernández |
|
| 16:50 - 17:00 |
Q&A |
|
|
17:00 - 17:20 |
Coffee Break |
|
|
17:20 - 17:30 |
Announcement Young Investigator Award Winners Giancarlo Comi |
|
|
17:30 - 18:00 |
Actrims Lecture Bruce A. Cree |
|
|
18:15 - 19:15 |
Satellite Symposium - Roche - Progression: Can we do better? |
| Hour Location |
Title | Location |
|---|---|---|
|
07:15 - 07:30 |
Light Breakfast |
|
|
07:30 - 08:30 |
Satellite Symposium - Janssen - Should we focus on inflammation to stop neurodegeneration and prevent progression? |
|
|
08:30 - 10:00 |
Session VII - Future Treatments: possible targets Per Soelberg Sørensen |
|
| 08:30 - 08:50 |
Axonal degeneration Gavin Giovannoni |
|
| 08:50 - 09:10 |
Expanding lesions Daniel Reich |
|
| 09:10 - 09:30 |
Astrocytes and microglia Francisco Javier Quintana |
|
| 09:30 - 09:50 |
Remyelination Hans-Peter Hartung |
|
| 09:50 - 10:00 |
Q&A |
|
|
10:00 - 10:30 |
Coffee Break |
|
|
10:30 - 11:00 |
Young Investigator Awards Giancarlo Comi |
|
|
11:00 - 12:30 |
Session VIII - Raising the bar to stop progression: a global approach Paola Zaratin |
|
| 11:00 - 11:20 |
PROMS Patrick Vermersch |
|
| 11:20 - 11:40 |
PMSA Robert Fox |
|
| 11:40 - 12:00 |
Role of industry Robert Hyde |
|
| 12:00 - 12:20 |
EMA Regulatory perspective on PMS Elena Hernandez Martinez De Lapiscina |
|
| 12:20 - 12:30 |
Q&A |
|
|
12:30 - 13:00 |
Concluding Remarks Giancarlo Comi |
|
|
13:00 - 14:00 |
Lunch |